Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q2 2025 · 10-Q
Revenue$548.87M$548.87M−8.0% vs Q2 2024 Net Income$35.34M$35.34MN/M vs Q2 2024 EPS Diluted$1.43$1.43N/M vs Q2 2024 Gross Profit$208,064,000+0.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$11,211,000−86.3% Free Cash Flowderived-$8,485,000N/M Margins · derivedGross margin37.9%+3.1 pt vs Q2 2024
Operating margin1.9%+0.6 pt vs Q2 2024
Net margin6.4%+10.0 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end